Company / Capital Expenditures
BIODESIX INC Capital Expenditures History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$259.0K
FY2025
5-year range
$259.0K / $22.9M
FY2021-FY2025
Trend
-92.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $23M to $259,000 over the past 2 years.
Based on SEC 10-K filings.
$259,000 in FY2025 with a 5-year CAGR of -33.2%.
Declined from $23M to $259,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -57.2%
- 5-Year CAGR
- -33.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -33.2%, indicating a declining trend.
- In FY2025, capital expenditures decreased 92.0% year-over-year.
- Peak capital expenditures was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -4.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $259.0K | -92.0% |
| FY2024 | $3.2M | -85.9% |
| FY2023 | $22.9M | +594.9% |
| FY2022 | $3.3M | +47.2% |
| FY2021 | $2.2M | +15.2% |
| FY2020 | $1.9M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026